Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-20

Clinical Trial Update: Effect of Oral Consumption of a Symbiotic Gelatin on the Presence of Gastrointestinal Symptoms and Quality of Life in People With Chronic Kidney Disease [NA]

View source ↗

Summary

This is a clinical trial update about an oral symbiotic gelatin study in people with chronic kidney disease; the trial is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Symbiotic Gelatin

Snippet

Sponsor: NIN Institute | Conditions: Chronic Kidney Disease(CKD), Dysbiosis Symptoms Linked to Pathology | NA | Status: ACTIVE_NOT_RECRUITING